U.S. Capital Markets Stock News

Dominion Energy’s stock has returned 49.2% over the past three years, and with the shares recently closing at US$69.85, investors now face a valuation puzzle where the market multiples screen the stock as undervalued while the broader checks give only a mixed verdict. A 49.2% return over three years puts Dominion Energy in the spotlight and raises the question of how much upside, if any, is left in the current price. Debate at the Virginia State Corporation Commission over who bears roughly...

Constellation Brands stock is trading near multi year lows after several years of weak share price returns, yet the broader valuation checks still suggest the shares lean cheap rather than expensive. Constellation Brands has fallen about 48.8% over the past 3 years, which puts the current share price in focus for investors assessing whether sentiment has swung too far to the downside. Growth in the beer segment and ongoing share buybacks can support the investment case, while a changing...

Lumentum Holdings has delivered an extremely strong 3 year share price run, yet its valuation checks are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while traditional market multiples lean towards the stock being expensive. The stock is up about 15x over the past 3 years, which puts extra focus on whether today’s price still offers a margin between market value and intrinsic value. Exposure to cloud data centers, AI infrastructure and semiconductor...

Peloton Interactive stock is drawing renewed scrutiny as a long stretch of weak returns meets valuation checks that indicate the shares are not a clear bargain, despite the recent bounce. Over the past 5 years, Peloton Interactive has fallen about 94.9%, which means long-term holders have seen most of their investment value erode. The valuation story now centers on whether Peloton can turn its connected fitness model into durable, profitable growth, while the risk is that ongoing execution...

Compass stock has delivered a very strong 172.6% return over the past three years, yet the latest checks suggest the shares now screen as expensive on market multiples even while the overall value score still looks supportive. A 172.6% three year return puts Compass firmly in the group of recent winners, which naturally raises the bar for what counts as an attractive entry price today. Recent analyst upgrades, housing market optimism and the removal of a legal overhang can support higher...

After a strong multi year run in the share price, First Financial Bancorp now sits at a point where its intrinsic value estimate suggests the stock may still be pricing in some upside, while the broader valuation checks paint a more mixed picture. First Financial Bancorp has returned 94.1% over the past 5 years, which puts current investors in the position of judging whether that kind of run has already captured most of the easy valuation gains. The agreed all stock acquisition of Finward...

Celldex Therapeutics stock has delivered a strong 59.5% return over the past year, yet the current valuation checks and market multiples point to a price that leans on the expensive side rather than a clear bargain. Over the past 12 months, Celldex Therapeutics has returned 59.5%, which puts extra focus on whether recent gains are already pricing in much of the expected progress. For a clinical stage biotech like Celldex Therapeutics, the prospect of advancing its pipeline can support higher...

NVR stock has delivered a 23.9% gain over the past five years, yet its valuation picture is mixed, with a Discounted Cash Flow (DCF) intrinsic value estimate that points to roughly fair pricing while some market multiple checks still screen the shares as undervalued. Over five years, NVR has returned 23.9%, which is a moderate outcome that does not clearly argue for either a bargain or an overextended stock by itself. Expectations for steady cash generation from NVR's homebuilding operations...

In recent days, Microsoft deepened its AI footprint by committing multibillions to expand Mistral’s European AI infrastructure while agreeing to deploy AMD’s Helios rack-scale AI systems and EPYC processors across Azure data centers. These moves tie Microsoft even more tightly to the core plumbing of global AI compute, reinforcing its role as an infrastructure partner to both frontier model developers and heavily regulated enterprises. We’ll now examine how Microsoft’s multibillion‑dollar...

Earlier in July 2026, Cloudflare announced the general availability of Precursor, a browser-based, continuous behavioral validation engine built on its edge network to detect and manage advanced bot traffic without using static CAPTCHAs. By monitoring full user sessions and logging only aggregate behavioral patterns such as timing and cadence instead of actual inputs, Precursor aims to improve bot detection while preserving end-user confidentiality and reducing friction for legitimate...

Neurocrine Biosciences (NasdaqGS:NBIX) has appointed Samir Siddhanti as Chief Business Officer. He will lead business development, corporate strategy, and alliance management for the company. The appointment follows Neurocrine Biosciences' recent US$2.9b acquisition of Soleno Therapeutics. Neurocrine Biosciences focuses on treatments for neurological, endocrine, and psychiatric conditions, an area that continues to attract attention from larger pharma partners and investors. With Siddhanti...

On 9 July 2026, Rackspace Technology cut its 2026 revenue guidance to US$2.45–2.55 billion, outlined an expected GAAP net loss for the second quarter, expanded its AI operating model collaboration with Palantir, and filed new shelf registrations including a US$250 million at-the-market common stock offering. The combination of lower near-term revenue expectations, an AI-focused pivot with Palantir targeting regulated industries, and fresh capital-raising capacity highlights a trade-off...

A German court ruling against Illumina (ILMN) over alleged patent infringement by its DNA sequencing systems has forced an injunction and recall in Germany, placing legal, operational, and reputational risks in sharper focus for investors. See our latest analysis for Illumina. The legal setback in Germany comes after a strong run in Illumina’s stock, with a 30-day share price return of 18.90% and a 90-day share price return of 47.53%. However, the 1-year total shareholder return of 88.70%...

Manchester United is pursuing a highly sought-after winger, with fresh competition emerging from AS Roma and other major clubs. AS Roma has already seen a significant bid rejected, while Arsenal and others are also reported to be interested in the player. The outcome of this transfer pursuit could influence Manchester United's squad planning and approach ahead of the new season. For investors watching NYSE:MANU, transfer activity is more than just headline noise; it feeds directly into how...

BXP has moved to sell the 99-year ground lease on its 1.2 million-square-foot, 91 percent leased 7 Times Square office tower in Manhattan for just over US$700,000,000, as part of its ongoing capital-raising and portfolio reshaping efforts ahead of its late-July 2026 quarterly results. The planned disposition of this well-leased, amenity-enhanced Class A asset highlights BXP’s willingness to recycle capital from prime properties to support its broader workplace and development...

With inflation risks tied to oil prices, shifting central bank paths and mixed growth signals across regions, many investors are looking for growth stories that appear aligned with both analyst research and management conviction. That is where the Fast Growing Stocks With High Insider Ownership screener can be useful, highlighting companies where growth expectations and insider commitment intersect. Insider ownership can help align leadership with shareholder interests, while strong growth...

Arbutus Biopharma and Genevant Sciences have launched new international patent litigation against Pfizer/BioNTech over mRNA lipid nanoparticle COVID-19 vaccine technology. The companies are seeking injunctions and monetary damages across Canada and much of the European Union related to Pfizer/BioNTech’s use of LNP technology. This legal action extends existing U.S. patent disputes into multiple major markets, widening the potential commercial impact for Pfizer’s mRNA franchise. Pfizer...

Sun Communities stock is caught between two conflicting valuation signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable gap to the current US$119.04 share price, while market based multiples suggest the stock is trading on the expensive side. After a 26.4% decline over the past 5 years, investors are left weighing up whether the current level reflects an opportunity or a value trap. The share price has declined 26.4% over 5 years, which raises the...

Event overview and why Harmony Biosciences stock is in focus Harmony Biosciences Holdings (HRMY) is back in focus after reiterating its 2026 net product revenue guidance of US$1.0b to US$1.04b, alongside a chief financial officer transition and an upcoming second quarter earnings release. See our latest analysis for Harmony Biosciences Holdings. The latest guidance confirmation, CFO transition and upcoming earnings date have come alongside a sharp swing in sentiment. The 1 day share price...

Applied Digital stock has delivered very strong long term returns over the past five years, yet the current valuation checks suggest the shares lean expensive rather than offering clear value. Applied Digital has returned about 313.9% over five years, which sets a high bar for any new investors looking for further upside from here. Investor attention around AI data center buildouts can support higher expectations for Applied Digital, but the sharp 35.5% share price fall over the past month...

PulteGroup stock has delivered a 144.1% total return over the past 5 years, yet the latest valuation work suggests it now sits close to its intrinsic value on a Discounted Cash Flow (DCF) basis while traditional earnings multiples still screen it as undervalued. That split leaves investors weighing solid long term gains against a picture that is no longer a clear bargain across every metric. PulteGroup's 144.1% return over 5 years highlights how much value the market has already recognized,...

Event setup: earnings expectations move into focus Lamb Weston Holdings (LW) is drawing attention after projections for its June 2026 quarter pointed to expected earnings of $0.62 per share and revenue above the level reported in the year-ago period. A positive Earnings ESP of 3.56% alongside a slightly lower consensus EPS estimate, but higher Most Accurate Estimate, has sharpened interest in whether Lamb Weston might outperform current earnings expectations. See our latest analysis for Lamb...

Mature digital platforms such as eBay are emerging as targets for AI focused activist-led buyouts. Activist investors are reportedly assessing NasdaqGS:EBAY for potential ownership and operational changes centered on AI adoption. The focus is on using AI tools and tighter execution to refresh underperforming parts of eBay's marketplace business. For investors watching eBay, the interest from AI oriented activists comes at a time when the stock is trading around $113.045, with a year to date...

Tariff headlines are back in focus after Sen. Ron Wyden moved to curb President Trump’s power to impose new trade barriers, and that puts U.S. retail stocks under a fresh policy spotlight. When tariffs are on the table, costs, pricing power, and political risk all compete for your attention. This article looks at how the proposed shift of tariff authority toward Congress could affect a select group of U.S. Retail Stocks, and what that might mean for your portfolio decisions. Ahead, you will...